---
title: "Oruka Therapeutics SVP Finance Arjun Agarwal disposes of 1,587 common shares worth $127,454.28"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290488665.md"
description: "Oruka Therapeutics SVP of Finance Arjun Agarwal sold 1,587 common shares on June 22, 2026. The transaction occurred at prices ranging from $80.01 to $82.15 per share, totaling approximately $127,454.28. Following this sale, Agarwal's direct holdings decreased to 15,312 shares. This information was published via EDGAR by Oruka Therapeutics Inc."
datetime: "2026-06-23T00:00:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290488665.md)
  - [en](https://longbridge.com/en/news/290488665.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290488665.md)
generator: "portal-rs"
---

# Oruka Therapeutics SVP Finance Arjun Agarwal disposes of 1,587 common shares worth $127,454.28

-   Oruka Therapeutics SVP of Finance Arjun Agarwal sold 1,587 common shares on June 22, 2026. \* Sales priced at $80.01 to $82.15; direct holdings fell to 15,312 shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oruka Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000907654-26-000066), on June 22, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [ORKA.US](https://longbridge.com/en/quote/ORKA.US.md)

## Related News & Research

- [Oruka Therapeutics Appoints Todd Edwards as Chief Commercial Officer | ORKA Stock News](https://longbridge.com/en/news/296823888.md)
- [Oruka Therapeutics SVP Finance Arjun Agarwal sells USD 840,975 in common shares](https://longbridge.com/en/news/292532295.md)
- [Nykode Therapeutics announces availability of Q2 2026 financial results report](https://longbridge.com/en/news/297025454.md)
- [BioXcel Therapeutics amends Oaktree-led credit agreement, extends deadline for refinancing deal to Aug. 28](https://longbridge.com/en/news/296776940.md)
- [Nykode Therapeutics to release Q2 financial results, host webcast presentation](https://longbridge.com/en/news/296641436.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**